chr17-63436148-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001915.4(CYB561):c.207G>A(p.Leu69Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,613,808 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0071 ( 14 hom., cov: 33)
Exomes 𝑓: 0.00069 ( 14 hom. )
Consequence
CYB561
NM_001915.4 synonymous
NM_001915.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.988
Genes affected
CYB561 (HGNC:2571): (cytochrome b561) Predicted to enable transmembrane monodehydroascorbate reductase activity. Predicted to be involved in ascorbate homeostasis. Predicted to be located in chromaffin granule membrane. Predicted to be active in lysosomal membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 17-63436148-C-T is Benign according to our data. Variant chr17-63436148-C-T is described in ClinVar as [Benign]. Clinvar id is 3034465.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.988 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00706 (1075/152318) while in subpopulation AFR AF= 0.0245 (1020/41572). AF 95% confidence interval is 0.0233. There are 14 homozygotes in gnomad4. There are 501 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYB561 | NM_001915.4 | c.207G>A | p.Leu69Leu | synonymous_variant | 3/6 | ENST00000360793.8 | NP_001906.3 | |
CYB561 | NM_001330421.2 | c.228G>A | p.Leu76Leu | synonymous_variant | 3/6 | NP_001317350.1 | ||
CYB561 | NM_001017916.2 | c.207G>A | p.Leu69Leu | synonymous_variant | 3/6 | NP_001017916.1 | ||
CYB561 | NM_001017917.2 | c.207G>A | p.Leu69Leu | synonymous_variant | 3/6 | NP_001017917.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00704 AC: 1071AN: 152200Hom.: 13 Cov.: 33
GnomAD3 genomes
AF:
AC:
1071
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00180 AC: 451AN: 250672Hom.: 7 AF XY: 0.00149 AC XY: 202AN XY: 135594
GnomAD3 exomes
AF:
AC:
451
AN:
250672
Hom.:
AF XY:
AC XY:
202
AN XY:
135594
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000686 AC: 1002AN: 1461490Hom.: 14 Cov.: 32 AF XY: 0.000612 AC XY: 445AN XY: 727036
GnomAD4 exome
AF:
AC:
1002
AN:
1461490
Hom.:
Cov.:
32
AF XY:
AC XY:
445
AN XY:
727036
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00706 AC: 1075AN: 152318Hom.: 14 Cov.: 33 AF XY: 0.00673 AC XY: 501AN XY: 74486
GnomAD4 genome
AF:
AC:
1075
AN:
152318
Hom.:
Cov.:
33
AF XY:
AC XY:
501
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CYB561-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at